Live
ePaper
Search
Live ePaper

Copyright 2025 - All Right Reserved.
ITV Network Ltd 2025

Home > India > BRIEF-Hansoh Pharmaceutical Says EMA Starts Reviewing Marketing Authorization Application For Aumolertinib

BRIEF-Hansoh Pharmaceutical Says EMA Starts Reviewing Marketing Authorization Application For Aumolertinib

Written By:
Last Updated: October 11, 2026 16:20:34 IST

Follow us on
Google News

Share

Oct 11 (Reuters) – Hansoh Pharmaceutical Group Company Limited: * SAYS IT RESUBMITTED EU MARKETING AUTHORIZATION APPLICATION FOR AUMOLERTINIB TO EMA * SAYS EMA VALIDATED APPLICATION AND REVIEW

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Ranji Trophy Scoreboard
J-League Summaries
Ranji Trophy Scoreboard
UPDATE 3-Pope Leo says will undergo surgery for small growth on lung
UPDATE 1-Ukraine will stop hitting refineries if Russia halts energy attacks, Zelenskiy says
UPDATE 2-Pope Leo says will undergo surgery for small growth on lung
BRIEF-Hansoh Pharmaceutical Says EMA Starts Reviewing Marketing Authorization Application For Aumolertinib
UPDATE 1-Pope Leo says will undergo surgery for small growth on lung
Bezzecchi pips Fernandez to win Indonesian GP, Martin retakes championship lead
Pope Leo says early-stage lung nodule detected, will undergo surgery

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Group Websites

QUICK LINKS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?